SIG
72
2
O
46
7
DHI
41
-4
STX
32
-5
PSA
32
-11
KO
55
8
IP
40
-11
LRCX
42
-3
PDCO
47
-8
NVDA
47
-9
BDX
37
-9
RSG
77
3
EFX
52
2
QCOM
66
-3
AIZ
69
3
SYY
60
3
BXP
50
11
DVN
46
2
QRVO
47
-7
UNH
48
2
SIG
72
2
O
46
7
DHI
41
-4
STX
32
-5
PSA
32
-11
KO
55
8
IP
40
-11
LRCX
42
-3
PDCO
47
-8
NVDA
47
-9
BDX
37
-9
RSG
77
3
EFX
52
2
QCOM
66
-3
AIZ
69
3
SYY
60
3
BXP
50
11
DVN
46
2
QRVO
47
-7
UNH
48
2
Financhill
Back

Cassava Sciences 10K Form

Sell
41

SAVA
Cassava Sciences

Last Price:
19.61
Seasonality Move:
1.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-12 10Q SAVA/Cassava Sciences Quarterly
2020-05-06 10Q SAVA/Cassava Sciences Quarterly
2020-03-26 10K SAVA/Cassava Sciences Annual
2019-10-29 10Q SAVA/Cassava Sciences Quarterly
2019-08-12 10Q SAVA/Cassava Sciences Quarterly
2019-05-02 10Q SAVA/Cassava Sciences Quarterly

Receive SAVA News And Ratings

See the #1 stock for the next 7 days that we like better than SAVA

SAVA Financial Statistics

Sales & Book Value

Annual Sales: $41.12M
Cash Flow: $-22.36M
Price / Cash Flow: 0
Annual Sales: $3.25
Price / Book: 6.18

Profitability

EPS (TTM): -2.32000
Net Income (TTM): $-97.22M
Gross Margin: $20.56M
Return on Equity: 0%
Return on Assets: 0%

Cassava Sciences Earnings Forecast

Key Cassava Sciences Financial Ratios

  • The Gross Profit Margin over the past 11 years for SAVA is 100.00%.
  • The Selling, General & Administrative Expenses for SAVA have been equal to 11.77% of Gross Profit Margin.
  • Per Share Earnings over the last 25 years have been positive in 10 years.

Cassava Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SAVA
CUSIP: 14817C
Website: cassavasciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 11.76

SAVA Technical Analysis vs Fundamental Analysis

Sell
41
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy or a Sell?

  • Cassava Sciences stock is rated a Sell
    The current Cassava Sciences [SAVA] share price is $19.64. The Score for SAVA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.